WHO announces start of Ebola vaccine clinical trial in DR Congo
The WHO has launched a clinical trial in the Democratic Republic of Congo to test the efficacy of the Ervebo vaccine against the Bundibugyo strain of Ebola. This trial is part of a broader effort to combat the country's worst-ever Ebola outbreak.
Why it matters
It represents a critical medical intervention in a public health emergency that has claimed thousands of lives.
x whatsapp-stroke copylink google Add Al Jazeera on Google info A health worker administers a dose of Ebola vaccine as part of the Tumaini trial in Ituri, the Democratic Republic of the Congo, on October 23, 2026 [Dieudonne Dirole/AP] By AFP Published On 24 Oct 2026 24 Oct 2026 The World Health Organization (WHO) has announced the beginning of the first clinical trial of an Ebola vaccine in the outbreak that started in the Democratic Republic of Congo (DRC).
WHO’s director-general, Tedros Adhanom Ghebreyesus, said in a social media post on Friday that participants in the trial were vaccinated with the Ervebo vaccine in Bunia, the capital of the DRC’s northeastern Ituri province, which is the epicentre of the Ebola outbreak.
Headlinne story · 3 newsrooms
Democratic Republic of Congo Launches Clinical Trial for Ebola Vaccine
What every outlet reported, where they differ, and how each framed it →
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in